We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape

By LabMedica International staff writers
Posted on 23 Dec 2024
Print article
Image: The new test could improve specialist transplant and transfusion practice as well as blood banking (Photo courtesy of NHS Blood and Transplant)
Image: The new test could improve specialist transplant and transfusion practice as well as blood banking (Photo courtesy of NHS Blood and Transplant)

The release of oxygen by red blood cells is a critical process for oxygenating the body's tissues, including organs and muscles, particularly in individuals receiving large blood transfusions. Healthy, fresh red blood cells have a characteristic biconcave shape, resembling a dumbbell, which facilitates efficient oxygen release. However, during refrigerated storage, red blood cells become energetically stressed and adopt a more spherical shape, slowing down their oxygen release. Researchers have now developed a method to assess the oxygen delivery capability of red blood cells by measuring their shape. This test could enhance practices in specialized transplant and transfusion settings, as well as improve blood banking procedures.

Researchers at the University of Oxford (Oxford, UK), in collaboration with NHS Blood and Transplant (London, UK), have created FlowScore, a formula designed to predict the rate at which red blood cells release oxygen. While earlier studies at Oxford's Department of Physiology, Anatomy, and Genetics identified factors affecting oxygen release from red cells, the testing method was too complex for routine use in blood centers focused on enhancing the monitoring of blood stored for transfusion. To adapt these findings for blood banking, NHS Blood and Transplant’s Component Development Laboratory joined the initiative, providing blood samples stored following NHS protocols and using measurements from hematology analyzers. These analyzers employ flow cytometry, which involves passing cells through a laser beam to examine their characteristics. The way light scatters off the cells reveals details about their size and shape.

The research, published in eBioMedicine, demonstrated that this information effectively predicts the oxygen release capacity of red blood cells, with the resulting predictive formula named FlowScore. This innovation simplifies, speeds up, and broadens access to red cell oxygen transport measurements for laboratories globally. Blood banks can now utilize FlowScore as a quality control tool during blood processing and storage. For instance, FlowScore helped quantify the positive effects of rejuvenating red blood cells and detect instances when blood handling deviated from blood bank standards. This could be crucial for monitoring the quality of stored blood in developing regions with higher ambient temperatures. Additionally, FlowScore may eventually offer a way to assess the quality of blood for specific patient groups if future research shows benefits for those populations.

“We find that FlowScore is a robust surrogate of oxygen-handling by red cells and provides new and important information on oxygen transport by the blood,” said Professor Pawel Swietach, Professor of Physiology at Oxford University. “Aside from its applications in transfusion medicine and blood banking, FlowScore can help identify new genetic, environmental and lifestyle factors that influence oxygen delivery to tissues.”

“FlowScore could become quite fundamental to the way blood is tested to ensure its quality,” added Dr. Peter Smethurst, from the NHSBT Blood and Transplant Component Development Laboratory. “It is a technical breakthrough that should improve the monitoring of stored blood and drive improvements that will most benefit vulnerable recipients of red cell transfusions.”

Related Links:
University of Oxford
NHS Blood and Transplant

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.